chr11-108250683-C-CT

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 2P and 16B. PVS1_ModerateBP6_Very_StrongBA1

The NM_000051.4(ATM):​c.1236-3dupT variant causes a splice acceptor, intron change involving the alteration of a non-conserved nucleotide. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★). The gene ATM is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.54 ( 20785 hom., cov: 0)
Exomes 𝑓: 0.37 ( 804 hom. )
Failed GnomAD Quality Control

Consequence

ATM
NM_000051.4 splice_acceptor, intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: -0.510

Publications

10 publications found
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
ATM Gene-Disease associations (from GenCC):
  • ATM-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • ataxia telangiectasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Laboratory for Molecular Medicine
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • gastric carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.040562645 fraction of the gene. Cryptic splice site detected, with MaxEntScore 12, offset of 0 (no position change), new splice context is: ccttttttttttttttttAGgct. Cryptic site results in inframe change. If cryptic site found is not functional and variant results in exon loss, it results in inframe change.
BP6
Variant 11-108250683-C-CT is Benign according to our data. Variant chr11-108250683-C-CT is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 181847.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.633 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
NM_000051.4
MANE Select
c.1236-3dupT
splice_acceptor intron
N/ANP_000042.3
ATM
NM_001351834.2
c.1236-3dupT
splice_acceptor intron
N/ANP_001338763.1Q13315

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
ENST00000675843.1
MANE Select
c.1236-18_1236-17insT
intron
N/AENSP00000501606.1Q13315
ATM
ENST00000452508.7
TSL:1
c.1236-18_1236-17insT
intron
N/AENSP00000388058.2Q13315
ATM
ENST00000531525.3
TSL:1
c.1236-18_1236-17insT
intron
N/AENSP00000434327.3H0YDU7

Frequencies

GnomAD3 genomes
AF:
0.540
AC:
76814
AN:
142254
Hom.:
20790
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.435
Gnomad AMI
AF:
0.664
Gnomad AMR
AF:
0.624
Gnomad ASJ
AF:
0.656
Gnomad EAS
AF:
0.434
Gnomad SAS
AF:
0.652
Gnomad FIN
AF:
0.591
Gnomad MID
AF:
0.777
Gnomad NFE
AF:
0.567
Gnomad OTH
AF:
0.577
GnomAD2 exomes
AF:
0.368
AC:
60152
AN:
163404
AF XY:
0.370
show subpopulations
Gnomad AFR exome
AF:
0.327
Gnomad AMR exome
AF:
0.386
Gnomad ASJ exome
AF:
0.384
Gnomad EAS exome
AF:
0.319
Gnomad FIN exome
AF:
0.385
Gnomad NFE exome
AF:
0.370
Gnomad OTH exome
AF:
0.380
GnomAD4 exome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.368
AC:
490593
AN:
1333196
Hom.:
804
Cov.:
0
AF XY:
0.369
AC XY:
244864
AN XY:
664030
show subpopulations
African (AFR)
AF:
0.296
AC:
8955
AN:
30258
American (AMR)
AF:
0.354
AC:
13518
AN:
38206
Ashkenazi Jewish (ASJ)
AF:
0.381
AC:
9098
AN:
23888
East Asian (EAS)
AF:
0.313
AC:
11725
AN:
37418
South Asian (SAS)
AF:
0.386
AC:
29534
AN:
76520
European-Finnish (FIN)
AF:
0.364
AC:
13776
AN:
37876
Middle Eastern (MID)
AF:
0.398
AC:
1834
AN:
4610
European-Non Finnish (NFE)
AF:
0.371
AC:
381896
AN:
1028950
Other (OTH)
AF:
0.365
AC:
20257
AN:
55470
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.417
Heterozygous variant carriers
0
16266
32532
48797
65063
81329
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14972
29944
44916
59888
74860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.540
AC:
76806
AN:
142278
Hom.:
20785
Cov.:
0
AF XY:
0.547
AC XY:
37485
AN XY:
68578
show subpopulations
African (AFR)
AF:
0.435
AC:
16785
AN:
38596
American (AMR)
AF:
0.624
AC:
8909
AN:
14282
Ashkenazi Jewish (ASJ)
AF:
0.656
AC:
2228
AN:
3396
East Asian (EAS)
AF:
0.434
AC:
2121
AN:
4882
South Asian (SAS)
AF:
0.653
AC:
2942
AN:
4506
European-Finnish (FIN)
AF:
0.591
AC:
4717
AN:
7988
Middle Eastern (MID)
AF:
0.772
AC:
213
AN:
276
European-Non Finnish (NFE)
AF:
0.567
AC:
37176
AN:
65518
Other (OTH)
AF:
0.578
AC:
1124
AN:
1944
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
1648
3296
4945
6593
8241
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
674
1348
2022
2696
3370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.280
Hom.:
575

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (7)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
2
not provided (2)
-
-
1
Ataxia-telangiectasia syndrome;C0346153:Familial cancer of breast (1)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
Breast neoplasm (1)
-
-
1
Familial cancer of breast (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.51
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34325032; hg19: chr11-108121410; COSMIC: COSV53729214; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.